PLSE
Pulse Biosciences, Inc Common Stock (DE)
Nasdaq · usd
Pulse Biosciences, Inc Common Stock (DE) (PLSE) trades at $46.36 (-8.09%) as of 7:30:03 PM EST on Nov 16, 2026, +4.34% over the past month. Market cap is $3.71B, with 8.3 days to cover in short interest.
Stock performance
How Pulse Biosciences, Inc Common Stock (DE) (PLSE) stock has performed from one day to one year, with its 52-week range.
- 1D
- -8.09%
- 1W
- -20.30%
- 1M
- +4.34%
- YTD
- +237.65%
- 1Y
- +241.38%
- 52-wk range
- $12.56 – $58.94
Key statistics
Today's trading snapshot for PLSE: day range, open, previous close, volume and market cap.
- Day range
- $46.03 – $51.56
- Open
- $51.24
- Prev close
- $50.44
- Volume
- 487.21K
- Market cap
- $3.71B
- Shares out
- 73.55M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Pulse Biosciences, Inc Common Stock (DE): P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 2483.14
- P/B
- 20.21
- P/FCF
- —
- ROE
- -45.6%
- ROA
- -41.5%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Nov 13, 2026
8-K filings
Material corporate events Pulse Biosciences, Inc Common Stock (DE) has disclosed to the SEC on Form 8-K.
- Clinical trial resultsNov 6, 2026
On November 6, 2026, Pulse Biosciences, Inc. announced interim six-month results from its PRECISE-BTN clinical study. The study is evaluating the Company's nPulse™ Vybrance™ Percutaneous Electrode System for the treatment of symptomatic benign thyroid nodules.
- Quarterly earningsNov 5, 2026
On November 5, 2026, Pulse Biosciences, Inc. (the "Company") announced certain financial and operational results for the fiscal quarter ended September 30, 2026.
- Partnership or collaborationOct 14, 2026
On October 14, 2026, Pulse Biosciences, Inc. (the "Company") announced entering into certain agreements with the Clayman Thyroid Center at the Hospital for Endocrine Surgery in Tampa, Florida, and its affiliates, which together form a commercial and clinical partnership between them to explore the clinical utility of the Company's proprietary nPulse Vybrance Percutaneous Electrode System.
- Deal terminationSep 15, 2026
On September 14, 2026, the Company terminated its at-the-market offering program in accordance with the terms of its prior equity distribution agreement... As of the time of its termination, shares of Common Stock having an aggregate offering price of up to $1.0 million remained unsold under the TD Cowen Distribution Agreement.
- Business updateSep 15, 2026
Enrollment was completed following an expansion of the Study from its original 50-patient design to 100 patients. All patients were enrolled across three U.S. clinical sites — Sarasota Memorial Health Care System, NYU Langone Health, and Weill Cornell Medicine — within approximately 12 months.
PLSE short interest
How heavily PLSE is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 8.3
- Short interest
- 2.9M
- Avg volume
- 351.72K
As of · reported to FINRA twice monthly.
PLSE news
The latest news and headlines about Pulse Biosciences, Inc Common Stock (DE) (PLSE).
- Pulse Biosciences, Inc (PLSE) Reports Q3 Loss, Misses Revenue EstimatesneutralZacks Investment Research· Nov 5, 2026
- Si-Bone (SIBN) Reports Q3 Loss, Tops Revenue EstimatesneutralZacks Investment Research· Nov 2, 2026
- Pulse Biosciences (PLSE) Q1 2025 Earnings TranscriptpositiveThe Motley Fool· May 4, 2026
- Oxford Industries, PVH And 3 Stocks To Watch Heading Into MondayBenzinga· Apr 1, 2024
- Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day SessionBenzinga· Mar 11, 2024
Frequently asked questions
What is the Pulse Biosciences, Inc Common Stock (DE) (PLSE) stock price today?
Pulse Biosciences, Inc Common Stock (DE) (PLSE) is trading at $46.36 (-8.09% on the day) as of 7:30:03 PM EST on Nov 16, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Pulse Biosciences, Inc Common Stock (DE)?
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a…
What is the short interest in PLSE?
As of Oct 30, 2026, PLSE has 2.9M shares short and 8.3 days to cover.
What exchange is PLSE listed on?
Pulse Biosciences, Inc Common Stock (DE) (PLSE) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.
Build with AI
Build an analysis of PLSE with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a PLSE analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.